重复经颅磁刺激辅助戒烟的多中心双盲随机对照试验
该多中心双盲随机对照试验纳入262例符合DSM-5烟草使用障碍的慢性吸烟者,比较双侧前额叶与岛叶皮质主动或假rTMS的戒烟效果。意向治疗集(N=234)第18周前四个月持续戒烟率主动组19.4%、假组8.7%(p=0.017),且主动组吸烟量与渴求下降更早更显著。
要点
- 主动rTMS第18周前持续戒烟率显著高于假rTMS(19.4% vs 8.7%,p=0.017)。
- 完成者中主动组与假组持续戒烟率分别为28.0%和11.7%(p=0.007)。
- 主动组在治疗第2周即出现吸烟量与渴求的显著更大下降。
核心结论
- 双侧前额叶与岛叶皮质rTMS是促进戒烟的安全方案,且为美国FDA首次批准rTMS作为成人戒烟辅助手段提供了依据。
研究设计与样本
- 多中心双盲随机对照试验纳入262例符合DSM-5烟草使用障碍的慢性吸烟者,至少一次既往戒烟失败,68%至少三次失败。
- 受试者接受三周每日双侧前额叶与岛叶皮质主动或假rTMS,随后每周一次共三周,每次rTMS前进行线索诱导渴求程序。
- 主要结局为意向治疗集第18周前四个月持续戒烟率(CQR),由每日吸烟日记和尿可替宁验证。
主要发现
- 意向治疗集(N=234)第18周前CQR主动组19.4%、假组8.7%(X2=5.655,p=0.017)。
- 完成者(N=169)第18周前CQR主动组28.0%、假组11.7%(X2=7.219,p=0.007)。
- 主动组吸烟量与渴求的下降在治疗第2周即显著大于假组。
关键数值与推荐
- 意向治疗集第18周前四个月持续戒烟率主动组19.4% vs 假组8.7%(p=0.017)。
- 完成者第18周前四个月持续戒烟率主动组28.0% vs 假组11.7%(p=0.007)。
临床怎么用
- 对至少一次戒烟失败的烟草使用障碍成人,可考虑双侧前额叶与岛叶皮质rTMS作为戒烟辅助手段。
- rTMS每次治疗前结合线索诱导渴求程序,可能增强戒烟效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation method increasingly used to treat psychiatric disorders, primarily depression. Initial studies suggest that rTMS may help to treat addictions, but evaluation in multicenter randomized controlled trials (RCTs) is needed. We conducted a multicenter double-blind RCT in 262 chronic smokers meeting DSM-5 criteria for tobacco use disorder, who had made at least one prior failed attempt to quit, with 68% having made at least three failed attempts. They received three weeks of daily bilat-eral active or sham rTMS to the lateral prefrontal and insular cortices, followed by once weekly rTMS for three weeks. Each rTMS session was administered following a cue-induced craving procedure, and participants were monitored for a total of six weeks. Those in abstinence were monitored for additional 12 weeks. The primary outcome measure was the four-week continuous quit rate (CQR) until Week 18 in the intent-to-treat efficacy set, as determined by daily smoking diaries and verified by urine cotinine measures. The trial was registered at ClinicalTrials.gov (NCT02126124). In the intent-to-treat analysis set (N=234), the CQR until Week 18 was 19.4% following active and 8.7% following sham rTMS (X2 =5.655, p=0.017). Among completers (N=169), the CQR until Week 18 was 28.0% and 11.7%, respectively (X2 =7.219, p=0.007). The reduction in cigarette consumption and craving was significantly greater in the active than the sham group as early as two weeks into treatment. This study establishes a safe treatment protocol that promotes smoking cessation by stimulating relevant brain circuits. It represents the first large multicenter RCT of brain stimulation in addiction medicine, and has led to the first clearance by the US Food and Drug Administration for rTMS as an aid in smok-ing cessation for adults.
引用
- Zangen A, Moshe H, Martinez D, et al. Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial. World Psychiatry. 2021. PMID: 34505368. doi:10.1002/wps.20905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。